Orgenesis (NASDAQ:ORGS) Stock, Quote.Headers.trade-ideas

Orgenesis

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

CNFR

CXAI

GNLN

GOOG

GOOGL

HSAI

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

HUYA

MKDW

ONON

ORGS

PACS

PLBY

PSIG

SPWR

SYRS

VSAT

YTRA

Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Intraday Update

AAGR

ADTN

ALUR

APLD

AREB

ASAN

BNAI

CABA

CDMO

CIFR

CLOV

CRKN

DMTK

GOSS

IPDN

KAVL

KRKR

MBIO

MINM

MOLN

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RELI

SHCR

SMTK

SPEC

SRPT

SWBI

TPHS

TREX

WAVE

ZCAR

Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Penny Stocks

Small Cap

ACON

ACOR

ADTX

ALLG

ASTS

AVTX

AWIN

CISS

CLSK

DCFC

GCTS

GOEV

GRTS

GUTS

JZXN

LIFW

MSTR

MVST

PPSI

PTPI

QDEL

SIGA

SNAX

TPET

VERV

VTSI

VVPR

XTIA

YTEN

Shares of  Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Orgenesis Inc

Orgenesis GAAP EPS of -$0.29, revenue of $0.14M

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Orgenesis</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/orgs-stock-quote/"><strong>ORGS</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Orgenesis reported earnings per share of -29 cents.</li><li>The company reported revenue of $141,000.</li><li>This was 98.83% worse than the analyst estimate for revenue of $12.00 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/orgs-stock-earnings-orgenesis-for-q1-of-2024/">ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024

The latest announcement is out from Orgenesis (ORGS). Orgenesis Inc. has created a presentation for potential investors and others, which is now ac...

Orgenesis Unveils Investor Presentation with Forward-Looking Insights

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Orgenesis</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/orgs-stock-quote/"><strong>ORGS</strong></a></span>) just reported results for the fourth quarter of 2023.</p><ul><li>Orgenesis reported earnings per share of -21 cents.</li><li>The company reported revenue of $165,000.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/orgs-stock-earnings-orgenesis-for-q4-of-2023/">ORGS Stock Earnings: Orgenesis Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

ORGS Stock Earnings: Orgenesis Reported Results for Q4 2023

Orgenesis files to sell 2.48M shares of common stock for holders

Orgenesis (ORGS) just unveiled an announcement. During Orgenesis Inc.'s 2024 annual stockholders' meeting, a key amendment was approved to increase...

Orgenesis Annual Meeting: Board Changes and Share Increase

Orgenesis (ORGS) just unveiled an announcement. Curtis Slipman resigned from his director position at Orgenesis Inc. for personal reasons, not due ...

Orgenesis Announces Board Reshuffle and New Audit Member

Orgenesis GAAP EPS of $0.23

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Orgenesis</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/orgs-stock-quote/"><strong>ORGS</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Orgenesis reported earnings per share of -23 cents.</li><li>The company reported revenue of $246,000.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/orgs-stock-earnings-orgenesis-for-q2-of-2024/">ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024

Orgenesis (ORGS) just unveiled an announcement. Orgenesis Inc. has prepared a presentation for potential investors and other interested parties, wh...

Orgenesis Releases Investor Presentation and Regulatory Update

Financing

Press Releases

Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing

Orgenesis Inc. Announces $2.3 Million Private Placement

Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference

Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility

Earnings

Orgenesis Provides Year End Business Update

Orgenesis Provides Business Update for the First Quarter of 2024

Orgenesis Provides Second Quarter 2024 Business Update

General

Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally

Health Care

Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Orgenesis

Orgenesis (ORGS) Forecast

Orgenesis (NASDAQ:ORGS) Stock, Quote.Headers.trade-ideas